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INTRODUCTION
The term biopiracy was first created by the non-governmental
organization, Action Group on Erosion, Technology and Concentration
("ETC Group," formerly known as RAFI). The ETC Group defined bi-
opiracy as the "appropriation of the knowledge and genetic resources of
farming and indigenous communities by individuals or institutions
who seek exclusive monopoly control (patents or intellectual property)
over these resources and knowledge."' Another and much simpler defi-
nition is robbery, or illegal appropriation of genetic material without
the consent of the interested parties.2 This illegal practice contributes
to environmental harm and imperils Brazil's biodiversity.
Biopiracy allows for inequitable profit distribution among the
states, big multinational corporations, and indigenous communities. It
is an undue appropriation of a country's natural resources without the
sharing of the benefits generated by the use of genetic resources. This
practice violates the provisions of the Convention on Biological Bi-
odiversity ("CBD").3 The CBD, in conjunction with the Nagoya
Protocol,4 regulates the use of natural resources and seeks to prevent
biopiracy internationally.
Brazil also has enacted domestic laws such the Provisional
Measure 2.186-16/20115 and the legislative decrees that followed 6 to
implement CBD's provisions. However, these laws are vague and not
strictly enforced. In Brazil, the uncontrolled withdrawal of natural re-
sources is a regular occurrence that threatens Brazil's rich biodiversity
and creates social injustices contributing to poverty within the indige-
1. The ETC Group, http://www.etcgroup.org/en/issues/biopiracy. (last visited) See also
Cynthia M. Ho, Biopiracy and Beyond: A Consideration of socio-cultural conflicts with
Global Patents Policy, 39 U. MICH. J.L. REFORM 433, 450 (2006),
2. DAVID HATHAWAY, A BIOPIRATARIA NO BRASIL [BiopiRAcY IN BRAZIL], IN SERIA
MELHOR MANDAR LADRILHAR? BIODIVERSIDADE, COMO, PARA QUE E POR QUE 182 (UnB ed.,
2008) (Br.).
3. Convention on Biological Diversity, opened for signature Jun. 5, 1992, 1760
U.N.T.S. 79 (entered into force Dec. 29, 1993), available at http://www.cbd.intl [hereinafter
CBD]. Biopiracy violates CBD's articles 8(j) and 15.
4. The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable
Sharing of Benefits Arising from their Utilization (ABS) to the Convention on Biological
Diversity, UN (2010), opened for signature Feb. 2, 2011, available at http://www.cbd.int/abs/
text/ [hereinafter Nagoya Protocol].
5. Medida Provis6ria No. 2186-16, available in English at http://www.mma.gov.br/
estruturas/sbf dpg/_arquivos/mp2186i.pdf [hereinafter MP].
6. Clarissa Bueno Wandscheer, Commons Resources in Brazil: Biopiracy,
Bioprospection, Biotechnology (Jun. 19, 2006) (unpublished conference paper, Indiana
University) (on file with Digital Library of the Commons, Indiana University), available at
http://dlc.dlib.indiana.edu/dlchandle/10535/611.
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nous community. The increase in poverty leads to corruption. The
indigenous peoples' lack of better opportunities accompanied by the
loss of natural resources allows for the growth of illegal trade in the
Amazon. The indigenous communities need to sell animals and plants
to meet their subsistence needs.
In addition to the actual exploitation that facilitates biopiracy,
existing patent laws also have a role in biopiracy activities. U.S. patent
law7 allows for biopiracy because it does not recognize foreign "prior
art."8 In addition, the international agreement on Trade Related As-
pects of Intellectual Property Rights (TRIPS)9 does not provide for
benefit-sharing or protection of traditional knowledge.
However, not all exploitation of a country's biodiversity is ille-
gal or is a case of biopiracy. Bioprospecting is the "legal" exploitation of
biodiversity for commercial purposes.' 0 It can be viewed as an incen-
tive for developing countries to protect biodiversity and traditional
knowledge while developing biotechnology."
Costa Rica is a good example of a developing country that views
bioprospecting as a way to protect biodiversity and promote sustaina-
ble development.12 The Merck-INBio bioprospecting agreement
between Merck pharmaceutical company and the Costa Rica INBio13
serves as a model of an agreement that takes into consideration envi-
ronmental conservation. 14
Part I of this paper provides an overview of the impacts of bi-
opiracy in the Brazilian Amazon. It illustrates how the illegal
exploitation of the fauna and flora puts species at risk of extinction. It
also examines the role of indigenous communities. Part II addresses
how the international legal framework that regulate benefit-sharing,
7. 35 U.S.C. § 101 (1952).
8. Id. § 103 (a). See also Vandana Shiva (U.S. Patent Act does not provide a general
definition of "prior art"), available at www.twnside.org.sg/title/tur-cn.htm.
9. Agreement on Trade-Related Aspects of Intellectual Property Rights, opened for
signature Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization,
Annex 1C, Legal Instruments - Results of the Uruguay Round vol. 31, 33 I.L.M. 1143, 1197-
1223 (entered into force Jan. 1 1995), available at http://www.wto.org/english/tratop-e/
TRIPS_e/TRIPSe.htm [hereinafter TRIPS].
10. Rachel Wynberg & Sarah Laird, Bioprospecting: Tracking the Policy Debate,
Environment 49 (December 2007) at 20, available at http://peopleandplants.squarespace.
com/sarah-laird-selected-publicati/.
11. Srividhya Ragavan, New Paradigms for Protection of Biodiversity, 13 J. INTELL.
PRoP. RIGHTS 515 (2008) (internal citations omitted).
12. Id. at 517.
13. National Biodiversity Institute, http://www.inbio.ac.cr/en/default.html [hereinafter
INBiol.
14. Ragavan, supra note 11, at 517.
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such as CBD and the Nagoya Protocol, play an important role in regu-
lating genetic resources' international commercialization. It considers
how such regulations affect the rise of biopiracy-related activities.
Part III discusses the role of intellectual property rights as a
hurdle to implement benefit-sharing. It examines the language of
TRIPS and how it conflicts with the CBD and the Nagoya Protocol. It
also provides a brief overview on how U.S. patents and trademark law
facilitates biopiracy by allowing for the registration of products native
to the Brazilian Amazon. It provides two examples of cases challenging
U.S. law where the patents were obtained by exploitation of India's
biodiversity.
Part IV describes Brazil's existing legal framework. It examines
the shortcomings of its current laws regarding bioprospecting contracts
and biodiversity protection. Furthermore, it identifies Costa Rica's suc-
cessful program, the Merck-INBios agreement. It examines how
bioprospecting can provide for biodiversity conservation and sustaina-
ble development.
Part V considers how Brazil could benefit from a contract like
the Merck-INBios agreement to control the exploitation of its natural
resources. This contract mandates that 50% of future royalties must be
invested to promote biodiversity conservation. It then explains how
changes in current legislation can prevent biopiracy, which will protect
the Amazon's rich biodiversity as well as the indigenous communities
that depend on the forest for their subsistence.
I. BiopiRAcY IN THE AMAZON FOREST
Brazil has 10% to 20% of all biodiversity in the entire planet,
more than any other nation.15 The Amazon forest holds most of the
Brazilian biodiversity and is home to various indigenous communities.
Brazil is a developing country in the process of pursuing significant
social and economic development. However, its biodiversity and indige-
nous communities are imperiled by this development.
Biopiracy not only encompasses the illegal trade of species of
animals and plants, but also the illegal appropriation and monopoly of
the knowledge of traditional populations regarding the use of natural
15. DANILo LOVISARO DO NASCIMENTO, BIOPIRATARIA NA AMAZONIA: UMA PROPOSTA
JURDICA DE PROTEqAO TRANSNACIONAL DA BIODIVERSIDADE E DOS CONHECIMENTOS
TRADICIONAIS ASSOCIADOs [BIOPIRACY IN THE AMAZON: A LEGAL PROPOSAL FOR THE
TRANSNATIONAL PROTECTION OF THE BIODIVERSITY AND THE TRADITIONAL KNOWLEDGE], 30
(Jurui ed., 2010) (Br.). See John Tustin, Traditional Knowledge and Intellectual Property in
Brazilian Biodiversity Law, 14 TEx. INTELL. PROP. L.J. 132 (2006) (internal citations
omitted).
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resources exiting in the environment. 16 This exploitation results in the
loss of property rights in natural resources essential for the indigenous
communities' survival.17 Moreover, this exploitation contributes to the
extinction of endangered species and serious environmental
degradation.18
Products and byproducts derived from Amazon biodiversity are
mostly used by the pharmaceutical and biotechnology industries (usu-
ally located in the North) and are also referred to as "green oil."9
Despite the very lucrative aspect of this activity, the exploited State
(usually located in the South) and the indigenous communities whose
knowledge helped the industry to find and market the green oil do not
receive any percentage of the foreign companies' profits.20
Biopiracy in the Amazon forest creates a vicious cycle. The for-
eign individuals and entities benefit from the traditional knowledge
and buy the resources needed at a very low cost. A very simple formula
of the exploitation emerges: free knowledge + cheap resource = millions
of dollars worth of products. Biopiracy causes Brazil to lose $16 million
per day, mostly as a result of lack of better public policy and poor en-
forcement of existing legislation.21
The pharmaceutical and biotechnology markets yield approxi-
mately $700 billion per year.22 The market for medicinal plants alone,
with the help of traditional knowledge, is $43 million. 23 Unfortunately,
most of the resources are obtained through biopiracy. Brazil and the
indigenous and other traditional communities do not participate. 24
A. The Illegal Extraction of Plants
The uncontrolled exploitation of plants is responsible for the
loss of Amazon biodiversity. The Brazilian Institute of the Environ-
ment and Natural Renewable Resources (IBAMA) estimates that
thousands of medicinal plants and wood are illegally exported each
16. NASCIMENTO, supra note 15, at 26.
17. Id.
18. Id.
19. VANDANA SHIVA, BiopiRAcY: THE PLUNDER OF NATURE AND KNOWLEDGE, 72 (South
End Press ed., 1997) [hereinafter SHIVA].
20. Id.
21. Darlene Menconi and Leonel Rocha, Riqueza Ameagada [Threatened Wealth], Isto
6, Sep. 24, 2003, at 92-98 (Br.).
22. HATHAWAY, supra note 2, at 183.
23. SHIVA, supra note 19, at 76.
24. HATHAWAY, supra note 2, at 186.
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year.25 Moreover, two thirds of the plants used by pharmaceutical com-
panies are from tropical rainforests. 26
Foreign scientists have come to Brazil to operate an NGO, alleg-
edly to promote conservation. 27 But the reality is that under the NGO
veil, they illegally work with the indigenous communities to catalog
plants and their medicinal capabilities and then sell them to foreign
corporations. 28
The wood trade is a significant threat to Brazil's tropical for-
ests. The United States, for example, is the largest importer of
mahogany. 29 The over-harvesting of this type of wood causes deforesta-
tion. Deforestation is a result of not only the extraction of the
mahogany tree itself, but also the cutting of trees in nearby areas due
to the need for open spaces to allow transportation of the logs. Defores-
tation causes habitat alterations and, consequently, loss of
biodiversity.30 Besides wood, many other plants are exported without
any regulatory measures. The Amazon native plants are largely used
in the pharmaceutical, cosmetics, food, and pesticide industries.3 1
Foreign companies obtained patents for many Brazilian plants.
For example, Aveda, a North American corporation, has a patent on
the "copaiba," an Amazon tree. The Body Shop, a British corporation,
has a patent on the fruit, "cupuagu," also found in the Amazon. 32
Merck Laboratories has a patent on the "jaborandi." "Jaborandi" con-
tains the "pilocarpina" molecule, which is an important component of
glaucoma medicine. 33
The most recognizable of the entire Brazilian flora is the "agai."
The agai is also known as "superfood" because of its many health bene-
fits. 3 4 In 2003, a Japanese company named K.K. Eyela Corporation
registered a patent on the "agai" berry. 35 In 2007, after pressure from
25. NASCIMENTO, supra note 15, at 36.
26. Id. at 37.
27. Id. at 48.
28. Id.
29. IBAMA, Geo Brasil 2002: Perspectiva do meio ambiente no Brasil, [Environmental
perspectives in Brazil] 43, available at http-//uff.academia.edufl'herezaCarvalho/Papers/
274499/GEOBrasil 2002_PerspectivasDoMeioAmbienteNoBrasil (Br.).
30. Id. at 45.
31. NASCIMENTO, supra note 15, at 38.
32. Wandscheer, supra note 6.
33. HATHAWAY, supra note 2, at 187.
34. 0 Estado de Sao Paulo, Brazil Regains "Agai" Trademark from Japan (2007), http://
www.amazonia.org.br/english/noticias/noticia.cfm?id=235363(lastvisited Sept. 15, 2011).
35. Id.
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Brazil, the Japanese company cancelled the patent. 3 6 In an attempt to
avoid international patents of its natural products, the Brazilian gov-
ernment created a list of more than 5,000 generic names of the
Brazilian biological resources and sent it to international organizations
to discourage registration. Although this initiative is a good start, it
has been questioned because there are trademarks already registered
in the U.S. for agai products .37
B. The Illegal Trade of Endangered Species
The trade of wildlife is the world's third largest illegal activity,
after guns and drugs.38 Brazil's participation in this trade is estimated
to be around 15%. Animals are traded for various reasons. Primates
are mostly used for biomedical research. Birds, reptiles and mammals
are used for pets, and for their byproducts, such as fur and skin.3 9
According to the National Report on the Illegal Trade of Wild-
life,4 0 illegal trade has three aspects. The first is the use of animals by
collectors and private zoos, which consists mainly of endangered and
rare species. 4 1 For example, a blue macaw (endangered) is worth
$60,000 in the international market.42 The second aspect of illegal
trade is the use of wildlife as pets and the sale to pet shops around the
world.43
Finally, the third aspect and the focus of this paper, is the ille-
gal trade of animals for scientific research. 4 4 This type of trade is
considered biopiracy. It targets species that have some kind of chemi-
cal substance, which could be used in medicine production. For
example, a type of snake called "jararaca-ilhoa" is worth about $20,000
36. Id.
37. DANIEL F. ROBINSON, CONFRONTING BiopItAcY: CHALLENGES, CASES AND
INTERNATIONAL DEBATES 92 (Earthscan ed. 2010) [hereinafter ROBINSON].
38. NASCIMENTO, supra note 15, at 35.
39. Id.
40. Relat6rio Final da 1 Comissao Parlamentar de Inquirito - CPI que investigou o
trifico de animais e plantas silvestres no pals. 0 documento foi elaborado e divulgado pela
CAmara dos Deputados [National Report on the Illegal Trade of Wildlife], RECNTAS,
available at http://www.renctas.org.br/pt/trafico/rel-cpi.asp (follow "Download relat6rio
completo") [hereinafter RECNTAS]. Comissdo Parlamentar de InquiritoDestinada a
"Investigar o trafico ilegal de animais e plantas silvestres da fauna e da flora
brasileiras"[National Report on the Illegal Trade of Wildlife] (2003)(documento foi elaborado
e divulgado pela C~mara dos Deputados Sarney Filho), available at http://www.renctas.org.
br/pt/trafico/rel cpi.asp (follow "Download relat6rio completo") (Br.).
41. Id.
42. Id.
43. Id.
44. Id.
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in the international market because of its venom.45 Similarly, the
brown spider's venom is being sold for $24,000.46 The possibility of new
medicines that could be manufactured from the substances produced
by these animals is very attractive to industries and the sale of these
animals is very lucrative to poachers.47
Developed countries are the most significant consumers of the
animals, through the "black market." According to the Brazilian Fed-
eral Police, 38 million animals are captured illegally, and 40% are
exported to developed countries. 4 8 This activity involves about $1 bil-
lion per year in Brazil. IBAMA recognizes that uncontrolled
exploitation of the Brazilian natural resources is the number one cause
for environmental degradation, which leads to the extinction of many
species .49
As a consequence of the illegal trade, developed countries have
a vast number of animals that are now legally bred in captivity.50 Ani-
mals from Brazil, such parrots and macaws, became popular and are
readily available throughout the world. Sadly, data shows that there
are more animals (native to Brazil) in captivity around the world than
in Brazil.51 Some species are facing extinction in Brazil, but are largely
bred in other parts of the world. 5 2
It is disturbing to know that 90% of the wildlife trade in Brazil
is illegal. Due to poor conditions in transportation and handling, only
one animal (out of ten captured) survives.53 Considering these num-
bers, loss of biodiversity is inevitable, not only in the Amazon forest,
but also in other parts of Brazil.
45. Id.
46. Id.
47. The Economist, Monkey Business: A Deadly but Lucrative Trade (2001), http://
www.economist.com/node/853197?story-id=853197 (last visited Sept. 15, 2011).
48. Portal Vegetariano Natureba, Trdfico de Animais Silvestres [Wildlife Trade], http:/
/www.natureba.com.br/trafico-animais-silvestres.htm (Br.). Portal Vegetariano Natureba,
Trifico de Animais Silvestres [Wildlife Trade], http://www.natureba.com.br/trafico-animais-
silvestres.htm (Br.)(last visited September 10, 2011).
49. Id.
50. Id.
51. Id.
52. NAscIMENTO, supra note 15, at 36.
53. See RECNTAS, supra note 40.
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C. Role of Traditional Communities: Knowledge and Participation
The Amazon forest is home to an estimated 20 million people.54
Biodiversity is a component of traditional knowledge. The traditional
communities of the Amazon, such as the indigenous people, the
"quilombolas" (African slaves descendents), and the population that
lives in small communities at the riverbanks called "ribeirinhos," de-
pend on the natural resources for their subsistence.55 They developed
techniques, not only of fishing and hunting, but also of how to use the
resources for medical purposes. For this reason, traditional communi-
ties play an important role in biopiracy.56
Traditional communities are victims and they need special pro-
tection against exploitation. Moreover, they need to be empowered and
informed about the role in conservation and sustainable development.
Their participation in biopiracy occurs in two ways: either because
their knowledge is stolen or because they were coerced to sell.5 7
Traditional knowledge is an essential part of biopiracy because
in order to know where to find the resources and what it can be used
for, the exploiters need the help of local communities. Posing as scien-
tist or tourist, the criminals deceive the people to obtain information.58
The communities that inhabit the Amazon are friendly, simple, and
mostly not well educated. The so-called scientist can easily pose as a
Good Samaritan and extract the information.
Another dimension of the problem is poverty. Because indige-
nous communities lack resources, the only means of survival is to sell
plants and animals for illegal trade. They constitute the first part of
the network for trade of endangered species, as recognized by the in-
vestigation on biopiracy initiated by the House of Representative in
2003.65 Moreover, the traditional populations are the main contribu-
tors to illegal trade of endangered species because of the high level of
poverty these communities face. The lack of resources in time of
54. Greenpeace, Amaz6nia: Salvar ou Destruir? (2005) [Amazon: Save or Destroy?]
http://www.greenpeace.org.br/tour2005 brl63/noticias.php?conteudo-id=2164 (Br.).
Greenpeace, Amaz6nia: Salvar ou Destruir? (2005) [Amazon: Save or Destroy?] http://www.
greenpeace.org.br/tour2005_brl63/noticias.php?conteudo-id=2164 (Br.)(last visited
September 10, 2011).
55. NASCIMENTO, supra note 15, at 28. Traditional communities are the people that
inhabit the Amazon and need natural resources for their subsistence. Id.
56. Id.
57. Id.
58. Id.
59. See RECNTAS, supra note 40.
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drought, for example, leads these communities to sell wildlife for
survival.60
Some groups are fortunate to become better informed about the
value of traditional knowledge with the help of nongovernmental orga-
nizations ("NGOs").61 A good example is the Natura case. Natura is a
leading cosmetic company in Brazil. In 2007, the Prosecutor's office
filed a civil action in the name of a tribe regarding possible use of un-
authorized traditional knowledge by the company. 62 This action is a
step in the right direction; however, much more needs to be done to
empower the traditional communities. Empowerment in the form of
education and best infrastructure63 is necessary to avoid exploitation.
The work of NGOs is essential in helping traditional communi-
ties to fight for their rights. A South African NGO, Biowatch, with the
support of an international NGO, Action Aid, brought into the media
attention, the exploitation of the knowledge of the San (the oldest
human inhabitants in Africa) by the South African-based Council for
Scientific and Industrial Research ("CSIR") for the use of a plant
known to suppress appetite. 64 Subsequently, the San started to receive
compensation for the use of their knowledge.6 5
Traditional populations worldwide are victims of political exclu-
sion, persecution, and many other limitations, including lack of legal
and civil rights.66 Their economic activities and subsistence are crucial
for the protection of the environment. Therefore, it is extremely impor-
tant to respect the human rights of these people so they can live their
lives with dignity. They need to understand the importance of protect-
ing their knowledge, their habitat, and the biodiversity around them.
60. Id.
61. Id.
62. Blog by Reinaldo Azevedo, Indios Atacam Exploragao Comercial da Natura
[Indians attack Natura's Commercial Exploitation], http://veja.abril.com.br/blog/reinaldo/
gerallindios-atacam-exploracao-comerical-da-natura-apoiada-por-marina/ (Br.). Posting of
Fabio Zanini to Reinaldo Azevedo's blog, Indios Atacam Exploravao Comercial da Natura
[Indians attack Natura's Commercial Exploitation], http://veja.abril.com.br/blog/reinaldo/
gerallindios-atacam-exploracao-comerical-da-natura-apoiada-por-marinal (Br.) (Jan. 9,
2009, 04:47 GMT).
63. See TheFreeDictionary.com (defining infrastructure as "the basic facilities,
services, and installations needed for the functioning of a community or society, such as
transportation and communications systems, water and power lines, and public institutions
including schools, post offices, and prisons," http://www.thefreedictionary.com/
infrastructure (last visited Sept. 15, 2011).
64. Laird, supra note 10, at 27.
65. Id. See also infra Part IV, A.
66. ROBINsoN, supra note 37, at 39.
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II. INTERNATIONAL LEGAL FRAMEWORK: BENEFIT-SHARING
International law plays an important role in biodiversity protec-
tion. As a result of animals migrating between continents and plants
being traded around the world, the increase in international trade of
biotechnology 67 created an interconnection between biodiversity con-
servation and intellectual property rights. Therefore, a number of
treaties exist today on the subject.68
In 1983, FAO International Undertaking on Plants Genetic Re-
sources stated, "Plant genetic resources are heritage of mankind to be
preserved, and to be freely available for use, for the benefit of present
and future generations."6 9 Since the South is the provider of most of
the world's biodiversity, the North always had an interest in guaran-
teeing free access to the biological resources from the South.70
Biodiversity has value and it is defined by international law as
"the variability among living organisms from all sources including, in-
ter alia, terrestrial, marine and other aquatic ecosystems and the
ecological complexes of which they are part; this includes diversity
within species, between species and of ecosystems."7' This very broad
definition encompasses not only animals and plants' intrinsic value as
living organisms but also the economic value of biodiversity. 72
The economic value of biodiversity can be measured by its di-
verse use and finality.73 Some examples are: wildlife trade, ecosystem
services, agriculture and food security, drugs and medicines. 74
67. CBD, supra note 3, Art. 2 defines "Biotechnology" as any technological application
that uses biological systems, living organisms, or derivatives thereof, to make or modify
products or processes for specific use, available at http://www.cbd.int/convention/text/.
68. For example, the Conference of the Parties to the CBD adopted a supplementary
agreement to the Convention known as the Cartagena Protocol on Biosafety to the
Convention on Biological Diversity. The Protocol is an international treaty governing the
movements of living modified organisms resulting from modern biotechnology from one
country to another and requires an advance informed agreement for the safe transfer,
handling and use of any living modified organism created by biotechnology that may have
adverse effect on the conservation and sustainable use of biological diversity. Cartagena
Protocol on Biosafety to the Convention on Biological Diversity art. 1, opened for signature
Jan. 29, 2000, 39 I.L.M. 1027 (entered into force Sep. 11, 2003). See Id. at art. 3, available at
http://bch.cbd.int/protocol/text/. Although part of the CBD treaty regime, the Biosafety
Protocol is beyond the scope of this paper.
69. DAVID HUNTER ET AL., INTERNATIONAL ENVIRONMENTAL LAW AND POLICY 1023 (3d
ed., Foundation Press 2007) [hereinafter HUNTER].
70. Id.
71. Id. at 1004.
72. Id.
73. Id.
74. Id. at 1008.
2012 301
FLORIDA A & M UNIV. LAW REVIEW Vol. 7:2:291
The three most relevant sources of international law on point
are the CBD, TRIPS, and the Nagoya Protocol. The CBD focuses pri-
marily on biodiversity conservation but also has an economic
component to it.76 Because of the economic value of biodiversity, the
principal objectives of the CBD are the "equitable sharing of the bene-
fits arising out of the utilization of genetic resources" and the
"protection of traditional knowledge."76 TRIPS, on the other hand, is
an intellectual property right ("IPR") agreement and its provisions con-
flict with the CBD because it only protects intellectual property rights
without acknowledging benefit-sharing or traditional knowledge.77 The
most recent development in the benefit-sharing context is the Nagoya
Protocol on Access to Genetic Resources and the Fair and Equitable
Sharing of Benefits Arising from their Utilization to the Convention on
Biological Diversity.78 The Nagoya Protocol's main goal is to ensure
that the parties to the agreement are adopting the benefit-sharing pro-
vision of the CBD.79
Accordingly, there is a rising international awareness that bi-
odiversity is indispensable to ensure the continuing existence of
human life on this planet. Therefore, conservation is a matter of sur-
vival and biopiracy practices need to come to an end worldwide.
A. The Convention on Biological Diversity
The Convention on Biological Diversity was adopted in June
1992, at the Rio Earth Summit in Rio de Janeiro, Brazil.80 The main
goal was to create an international framework for the sustainable use
of the planet's natural resources.8 1
The parties negotiating the convention came to the realization
that preservation of biodiversity was a "common concern of human-
kind."82 Although States have the right to maintain their sovereignty,
75. Id. at 1032.
76. Id.
77. Id. at 1050.
78. Melissa Lewis, Bioprospecting in the Wake of CBD COP10: The adoption of the
Nagoya Protocol, 19 ILSA Quarterly 2, 18 (2010) [hereinafter Lewis].
79. Id.
80. The Convention on Biodiversity, available at http://www.cbd.int/history/ ("The
Convention entered into force on 29 December 1993, which was 90 days after the 30th
ratification.").
81. Id. "The Convention on Biological Diversity was inspired by the world community's
growing commitment to sustainable development. It represents a dramatic step forward in
the conservation of biological diversity, the sustainable use of its components, and the fair
and equitable sharing of benefits arising from the use of genetic resources." Id.
82. HUNTER, supra note 69, at 1023.
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they also have the responsibility to preserve the natural resources
within their territory for the sake of the rest of the world.83
Despite the criticism regarding the vague language of the CBD,
the Convention has numerous positive environmental concepts. The
Convention encourages sustainable use of natural resources through
its State members' national conservation laws. 8 4 It provides for the rec-
ognition of traditional knowledge and its relevance towards
biodiversity conservation.85 The CBD also recognizes that countries
have the sovereign right over their genetic resources. This right gives
the developing countries, the source of most genetic resources, some
bargaining power to employ against the developed countries, because
the latter hold the technology to explore the resources.86
One of the most controversial articles of the CBD is Article 15,
the benefit-sharing provision.87 Sections 6 and 7 establish that com-
pensation should be given for the use of a country's genetic resources.88
This means an equitable part of the benefits and results obtained from
the utilization of genetic resources or the traditional knowledge associ-
ated with these resources should be shared.8 9 In other words, the
South facilitates access to biodiversity for commercial purposes and the
North should pay for it. This is the legal type of biopiracy also known
as bioprospecting.90 The objective of the benefit-sharing provision is
that the countries rich in biodiversity can make agreements to trade
access to genetic resources for a good share of the benefits.91
The Bonn Guidelines on Access to Genetic Resources and Fair
and Equitable Sharing of the Benefits Arising out of their Utilization
were adopted in 2002, by the Parties signatories of the CBD, to facili-
tate the understanding on how the benefit-sharing provision would
work in practice.92 Developing countries believed that it is more than
fair that the exploitation of the South's natural resources should be
83. Id.
84. CBD, supra note 3, at art. 6.
85. Id. at art. 8 (j).
86. Michael Blakeney, Bioprospecting and Biopiracy, reprinted in Intellectual Property
and Biological Resources at 405 (Marshall Cavendish International ed., 2004).
87. Sandra Akemi Shimada Kishi, Visdo Critica Sobre a Convengdo da Biodiversidade:
Seus Objetivos, Soberania Estatal e Accesso ao Conhecimento Traditional [Critical View of
the Convention on Biodiversity: Objectives, State Sovereignty and Access to Traditional
Knowledge], 6 Revista Internacional de Direito e Cidadania [REID] 214 (2010) (Br.).
88. Id. at 215.
89. Id.
90. SHIVA, supra note 19, at 74.
91. HUNTER, supra note 69, at 1037.
92. Id. at 1038.
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compensated.93 However, it is important to note that this compensa-
tion, which is usually in the form of royalties, should be invested in the
conservation of the biodiversity.94 Under the principle of sustainable
development, the compensation will ensure that the natural resources
will be available to future generations.95 A portion of this compensa-
tion should also be reserved for the traditional communities whose
knowledge allows for locating and using the natural resources. 96
The United States signed but did not ratify the convention.9 7 Its
main objections were the provisions of intellectual property, benefit-
sharing, and the requirements for domestic conservation.98 Home to
major pharmaceutical companies, the U.S. holds many patents on ge-
netic resources located in other countries.9 9 Therefore, the U.S. has no
interest in benefit- sharing, only in benefiting.100
B. The Nagoya Protocol
The Nagoya Protocol is the latest international development in
the CBD treaty regime.101 One of the most important objectives of the
CBD is access to genetic resources and benefit- sharing provided in Ar-
ticle 15 of the Convention. 102
By recognizing the sovereign rights of the provider States over
their natural resources, the Convention established that States have
the authority to determine access to genetic resources in areas within
their jurisdiction.1 0 3 Moreover, the member States have the obligation
to ensure the sharing of the benefits derived from their use. 104 CBD
93. Id.
94. Id. at 1042.
95. Michael I. Jeffery, Intellectual Property Rights and Biodiversity Conservation:
Reconciling the Incompatibilities of the TRIPS Agreement and the CBD, reprinted in
Intellectual Property and Biological Resources 186 (Marshall Cavendish International ed.,
2004).
96. Id.
97. HUNTER, supra note 69, at 1022
98. Id.
99. Id.
100. See infra section III, subsection B.
101. The Nagoya Protocol, supra note 4
102. Id. "The Nagoya Protocol on Access to Genetic Resources and the Fair and
Equitable Sharing of Benefits Arising from their Utilization (ABS) to the Convention on
Biological Diversity is a supplementary agreement to the Convention on Biological
Diversity. It provides a transparent legal framework for the effective implementation of one
of the three objectives of the CBD: the fair and equitable sharing of benefits arising out of
the utilization of genetic resources."
103. The Nagoya Protocol Background, supra note 4.
104. Id.
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also encourages the equitable sharing of the benefits derivative from
traditional knowledge as an important practice for the conservation
and sustainable use of biodiversity.105
State parties to the CBD adopted the Nagoya Protocol on Access
to Genetic Resources and the Fair and Equitable Sharing of Benefits
Arising from their Utilization to the Convention on Biological Diversity
at the Tenth Meeting of the Conference of the Parties, held in Nagoya,
Japan, in October 2010.106
The Nagoya Protocol is an
international agreement which aims at sharing the benefits arising
from the utilization of genetic resources in a fair and equitable way,
including by appropriate access to genetic resources and by appro-
priate transfer of relevant technologies, taking into account all
rights over those resources and to technologies, and by appropriate
funding, thereby contributing to the conservation of biological di-
versity and the sustainable use of its components.107
The Protocol supplements the CBD and it provides a more de-
tailed legal framework on how to accomplish the CBD's objective for
benefit-sharing. 08 The Protocol requires that its provisions be imple-
mented by its State parties into domestic legislation.109
The main goal of the Nagoya Protocol is to create more legal
certainty and transparency for the State providers and users of genetic
resources.' 10 It aims to do so by establishing more predictable condi-
tions for access to genetic resources and ensuring benefit-sharing when
genetic materials are taken outside the provider jurisdiction.,,"
The Protocol will enter into force 90 days after being ratified by
at least fifty parties to the CBD and is open for signature at the UN
headquarters in New York, until February 1, 2012.112 It will only be
successful if the States cooperate to make benefit-sharing a reality.113
The success also depends on the adoption and enforcement of strong
domestic legislation by the parties to the agreement.114
105. Id.
106. Id.
107. Access and Benefit Sharing, available at http://www.cbd.int/abs/ [ABS]. (last
visited date)
108. Id.
109. Lewis, supra, note 78, at 20.
110. Id. at 21.
111. Id.
112. ABS, supra note 107.
113. Id.
114. Id.
2012 305
FLORIDA A & M UNIV. LAW REVIEW Vol. 7:2:291
The Protocol it is a great step toward ending biopiracy because
these transactions are to be made contractually, which could guarantee
economic resources used for conservation and compensation for tradi-
tional knowledge.115 The adoption of this benefit-sharing agreement
will help traditional communities and developing countries to over-
come the lack of protection from domestic and international
intellectual property rights laws.
III. INTELLECTUAL PROPERTY RIGHTS HURDLE
IPRs have caused much debate throughout the years, in partic-
ular, after the adoption of the CBD. Developed and developing
countries have a different understanding of patent rights. The former
have advocated for a more liberal approach in the granting of patents
and for more strict enforcement of the rights arising from the patents,
while the latter have to abide by the strict laws to continue develop-
ing.116 Developing countries maintain that they are in an inferior
position when it comes to IPRs, especially in the context of
biodiversity.117
A. The Agreement on Trade-Related Aspects of
Intellectual Property Rights
The CBD's benefit-sharing provision generated much discussion
and conflict in the international community.118 There is a close rela-
tionship between IPRs and benefit-sharing as it relates to
biodiversity. 19
Both the States providing genetic resources and responsible for
biodiversity conservation, and the States receiving the genetic re-
sources for industrialization of products, are aware of the relevance of
the IPRs for the protection of biotechnological inventions.120 Moreover,
115. Lewis, supra note 78, at 23.
116. Alan S. Gutterman, The North-South Debate Regarding the Protection of
Intellectual Property Rights, 28 WAKE FOREST L. REV. 89, 90-91 (1993) [hereinafter
Gutterman].
117. Id. at 136-37 ([It has become evident that expanded protection of IP rights is not
sensible for all countries; neither is it wise to allow the United States and other developed
countries to impose their conventions upon the rest of the world.) Id.
118. Jeffery, supra note 95, at 185.
119. Id.
120. Id.
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IPRs are also important for the protection of traditional knowledge
used to create the products.121
The CBD requires that intellectual property rights be "support-
ive of and do not run counter to" to the treaty's objectives.1 22 During
the CBD negotiations, the South argued that IPRs protect the patents
of biotechnology industries and pose a major obstacle to benefit-shar-
ing, because IPRs make it more difficult to transfer technology as it is
protected under patent laws. 123 On the other hand, the North claimed
that any technology transfer had to honor the intellectual property
rights of industry from the North. 124 Both sides believed that their
view would allow for better biodiversity conservation. 125 The results of
these debates are the CBD's articles articulating benefit-sharing and
the protection of traditional knowledge, but also acknowledging
IPRs. 126 The CBD created a balance of the interests between the
North and South by recognizing that IPRs and biodiversity regulation
are closely linked. 127
The Agreement on Trade-Related Aspects of Intellectual Prop-
erty Rights ("TRIPS") was negotiated under the umbrella of GATT 128
and WTO, 12 9 after the creation of the CBD, and entered into force in
1995.130 It is very comprehensive and set standards for protection of
IPRs. 131 Notably, patents are the most well known form of IPRs.132
121. Id. at 186.
122. HUNTER, supra note 69, at 1050.
123. Id. at 1034.
124. Id.
125. Id.
126. Id.
127. Id.
128. General Agreement on Tariffs and Trade, Oct. 30, 1947, 55 U.N.T.S. 194; 61 Stat.
pt. 5; T.I.A.S. No. 1700. (The General Agreement on Tariffs and Trade (GATT) was an
international agreement that promoted international trade and the reduction of trade
barriers among member states from 1947-1994. Under the GATT regime, subsequent
agreements resulted in trading "rounds." The Uruguay Round created the World Trade
Organization, which forms the legal and institutional framework for the multilateral
trading system.) See HUNTER supra note 69 at 1257.
129. The World Trade Organization (WTO) is the only global international organization
dealing with the rules of trade between nations. At its heart are the WTO agreements,
negotiated and signed by the bulk of the world's trading nations and ratified in their
parliaments. The goal is to help producers of goods and services, exporters, and importers
conduct their business. available at http://www.wto.org/english/thewtoe/whatis-e/
whatis e.htm.
130. Jeffery, supra note 95, at 193.
131. Id.
132. Id.
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Article 27 of TRIPS established that plant varieties could be
patented. 133 This conflicts with the CBD because it does not mention
benefit-sharing or any kind of protection of traditional knowledge. 134
Many developing countries, including Brazil, argue that Article 27
needs to be amended to include sharing of the benefits derivative of the
patents from plants varieties.135 Brazil also argues that the amend-
ment should contain identification of the source, identification of the
traditional knowledge from where the resources were obtained, and
prior consent of the country.136 According to Brazil these changes
would help prevent biopiracy. 3 7
TRIPS undermines the CBD because Article 27 is incompatible
with the benefit-sharing provision.138 IPRs protection bars the transfer
of technology. 139 Once a country retains the patent of a product, it will
not share the information about that product.140 As a result, the pro-
vider country will not be able to get recognition for the supply of the
genetic materials and the knowledge of the traditional peoples.141
TRIPS have a negative impact on biodiversity conservation, be-
cause it allows patenting of life forms.142 It undermines the value of
natural resources and traditional knowledge by placing more value on
IPRs.143 It changes the "socio-cultural context of conservation."144
No amendments to TRIPS Art. 27 have been made as of this
writing.145 The bio-pharmaceutical and biotechnological industries
have significant influence on how international property law will de-
velop. They want to ensure the most profitability for the rights to the
use of genetic resources.
133. Id.
134. Id.
135. HUNTER, supra note 69, at 1051.
136. Id.
137. Id. at 1052-1053.
138. Id.
139. Id.
140. Id.
141. Jeffery, supra note 95, at 206.
142. SHIVA, supra note 19, at 87.
143. Id. at 88.
144. Id. TRIPS impacts not only the ecology of species interactions as a result of the
commercial release of patented genetically engineered organisms (GEOs), but also
undermines rights of local traditional communities and their relationship to biodiversity
affected by invasion of the GEOs into their environment, diminishing the community
capacity to conserve biodiversity.
145. Id.
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B. U.S. Patent Law
The United States Patent and Trademark law is frequently
blamed for being responsible for some of the most controversial cases of
biopiracy.146 Under the international IPR framework, the TRIPS
agreement was influenced by the U.S. interest in preserving its domes-
tic patent law. 147 Developing countries accuse U.S. patent law of
having a low standard with respect to foreign knowledge. 148 For exam-
ple, under the novelty rule,14 9 a person is entitled to a patent unless
the invention was known or used by others in this country [U.S.], or
patented or described in a printed publication in this or a foreign coun-
try, before the invention thereof by the applicant for the patent. 150 The
rule only mentions foreign patents and printed publications. It does
not mention foreign knowledge or use.151 The priority rule establishes
that whoever is the first to invent has priority to patent. 152
Biopiracy allegations are premised on the fact that patents of
genetic material are not inventions, because they are identical to the
actual genetic resources itself.153 For example, a dispute between the
United States and India arose regarding the Neem tree.154 The Neem
tree only exists in India and is well known as the "curer of all ail-
ments."155The Neem tree has been used in India for over 2,000 years as
medicine, pesticides, spermicides, toothbrushes and other purposes.156
It is also considered sacred by Indian citizens. 15 7 In 1971, a U.S. timber
company began utilizing the Neem seed to produce pesticides.158 The
company was granted a patent and subsequently sold its rights to an-
146. Cynthia M. Ho, Biopiracy and Beyond: A Consideration of socio-cultural conflicts
with Global Patents Policy, 39 U. MICH. J.L. REFORM 433, 508-509 (2006) [hereinafter Ho].
147. Id.
148. Charles McManis, Fitting Traditional Knowledge Protection and Biopiracy claims
into existing IP and unfair competition framework, reprinted in Intellectual Property and
Biological Resources 451 (Marshall Cavendish International ed., 2004) [hereinafter
McManis].
149. 35 U.S.C. § 102 (a) (1952).
150. McManis, supra note 148, at 452.
151. Id.
152. 35 U.S.C. § 102 (g).
153. Ho, supra note 146, at 449.
154. Id.
155. HUNTER, supra note 69, at 1046.
156. Sara Hasan, The Neem Tree, Environment, Culture and Intellectual Property,
TED Case Studies, 2002, http://www.american.edulTED/neemtree.htm.(last visited date).
157. Id.
158. Id.
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other U.S. company, W.R. Grace. 15 9 W.R. Grace sued Indian companies
for breach of patent law for making an emulsion extracted from the
Neem tree also used as pesticide.160
The novelty rule establishes that the invention must be
"new."161 W.R. Grace satisfies the "new" requirement because their fin-
ished product does not exist in nature.162 The rule also states that the
invention cannot be a component of "prior art" or existing knowl-
edge.163 India claims that the U.S. statute opens the door to biopiracy
and that the U.S. has to change the language of its patent law. 164 The
suggested change is the recognition of foreign "prior art" that is based
on the ancient practice of a country and deeply imbedded in its tradi-
tion, even though it has not being patented or published.165 Oral
information should have the same status as written information for
purposes of the novelty rule. 66
Europe also had a patent on a method of controlling fungi on
plants using extracted Neem oil, but revoked the patent based on the
fact the fungicidal effect of Neem seed extracts has been used for cen-
turies in India. 6 7 However, such a well-known fact would not cause
the revocation of the patent in the U.S. because the government does
not consider public use in foreign countries as relevant prior art unless
such use is documented in writing. 168
The turmeric case is another example of India challenging a
U.S. patent under biopiracy allegations.s69 Turmeric has been used in
India for centuries as dye, cooking and medicine. 70 In 1995, a patent
was awarded under the novelty rule to the University of Mississippi
Medical Center for the use of turmeric in wound healing. 171 India sued
and the patent was revoked only because some written documentation
was found.172
159. Id.
160. Id.
161. Vandana Shiva, The Turmeric Patent is Just the First Step in Stopping Biopiracy,
Third World Network, www.twnside.org.sg/title/tur-cn.htm. (last visited date).
162. Id.
163. Id.
164. Id.
165. Id.
166. Id.
167. Id.
168. Id.
169. Alyson Slack, Turmeric, TED Case Studies, 2004, www.american.edu/ted/turmeric.
htm. (last visited date).
170. Id.
171. Id.
172. Id.
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Brazil, India, other developing countries and NGOs have criti-
cized the U.S. patent laws and their relationship to TRIPS
provisions.173 They proposed an amendment to TRIPS to include a pro-
vision mandating disclosure of the source of genetic material and
traditional knowledge.174 This disclosure mechanism in patent applica-
tion would avoid the granting of patents for materials used in other
countries.' 75 The examiners would be able to establish if the material
was prior art and therefore lacked novelty status.176
The U.S. biotechnology industry has been very profitable under
the protections of the current patent law framework. 77 It is very un-
likely the traditional knowledge of useful genetic resources around the
world is fully registered and publicized in writing. Therefore, the in-
dustry can continue its research and patent its findings both under
domestic and international IPR laws. The simple solution of including
oral information into the novelty rule that could help end biopiracy
worldwide is unlikely to happen.
IV. DOMESTIC IMPLEMENTATTON: COMPARATIVE LAW ISSUES
The parties to the CBD are required to find viable models for
implementation of the CBD's objectives at the national level.' 78 Brazil
created a complex framework to implement the CBD's objectives and
address biopiracy. However, the Brazilian laws are flawed and do not
establish an equitable system for regulating traditional knowledge as-
sociated with genetic resources and, therefore, are not effective in
combating biopiracy. On the other hand, developing countries such as
Costa Rica, developed a more effective system to implement CBD's
goals.
A. Brazilian Legal Framework: Shortcomings of the Current
System in Brazil
One of the biggest challenges Brazil faces to combat biopiracy in
the Amazon is the lack of strong legal instruments that would effec-
173. HUNTER, supra note 69, at 1052.
174. Id.
175. Id.
176. Id.
177. Amy E. Carroll, Not Always the Best Medicine: Biotechnology and the Global
Impact of U.S. Patent, 44 AM. U. L. REV. 2452 (1995) (internal citations omitted)
[hereinafter Carroll].
178. See Implementation Mechanisms, http://www.cbd.int/convention/mechanisms/ (it
provides information through a internet based-network).
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tively regulate access to biodiversity.179 There are however, a group of
federal laws that complement the Federal Constitution.18o
The legal framework responsible for regulating research, bi-
odiversity use, and benefit-sharing is extensive. All of the laws
followed the ratification of the CBD as domestic implementation mech-
anisms. The most important regulations are: Decree 2.519/98, Medida
Provis6ria 2.186-16/01, and Decrees 3.945/01, 4.339/02, 4.946/03,
5.439/05, 5.459/05, 6.159/07.181 This paper will focus on the Medida
Provis6ria 2.186-16/01 ("MP 2186") as the principal legal instrument
addressing commercial use of genetic resources and traditional
knowledge. 182
1. The Brazilian Federal Constitution
The Brazilian Federal Constitution ("Constitution") is the coun-
try's highest law and expresses the national principles and values
regarding the conservation of Brazil's biodiversity.1 8 3 It recognizes that
biodiversity belongs to the people.184 The Constitution's relevant arti-
cles establish federal guidelines for scientific research, the right to a
healthy environment, environmental conservation, and protection of
indigenous people and traditional knowledge.185
The provision for scientific research is found in Article 218,
which provides "the State shall promote and foster scientific develop-
ment, research, and technological expertise."s86 Section 2 requires that
this research must focus primarily on the solution of Brazilian
problems for the development of the Brazilian productive systems.18 7
The right to a healthy environment in Article 225 guarantees to all
Brazilian citizens "the right to an ecologically balanced environ-
179. NASCIMENTO, supra note 15, at 90
180. Id.
181. Id. at 89.
182. MP, supra note 5.
183. Robin L. Scott, Bio-Conservation or Bio-Exploitation: An Analysis of the Active
Ingredients Discovery Agreement Between the Brazilian Institution BIOAMAZONIA and the
Swiss Pharmaceutical Company NOVARTIS, 35 GEO. WASH. INT'L L. REV. 985 (2003)
(internal citations omitted) [Scott].
184. Id.
185. Id. at 986.
186. Constituigio da Repdblica Federativa do Brasil de 1988, art. 218 [Constitution of
the Federative Republic of Brazil of 1988], available in English at http://www.stf.jus.br/
repositorio/cms/portalStflnternacional/portalStfSobreCOrteen us/anexo/constituicao
ingles_3ed2010.pdf [hereinafter C.F.].
187. Id. § 2.
312
BIOPIRACY IN THE BRAZILIAN AMAZON
ment." 88 This provision also incorporates the sustainable development
principle and imposes on the government "the duty to defend and to
preserve the environment for present and future generations." 8 9 Sec-
tion 1 states that the government is responsible for the preservation of
the "diversity and integrity of the Country's genetic patrimony" and for
the supervision of "entities dedicated to research and manipulation of
genetic material." 190
Indigenous peoples' right to land and natural resources is ex-
pressed in Article 231. It recognizes the "social organization, customs,
languages, creeds and traditions" of Brazilian indigenous people and
protects their interests in as well as their original rights to "the lands
they traditionally occupy."19' Section 1 explains that traditionally oc-
cupied lands are "those on which [the indigenous people] live on a
permanent basis, those used for their productive activities, those indis-
pensable for the preservation of environmental resources necessary for
their well-being and those necessary for their physical and cultural re-
production, according in their uses, customs and traditions." 192 In
addition to section 1 of Article 231, section 6 establishes that any ex-
ploitation of the natural wealth of these lands is "null and void" or has
no legal effect, "except in the case of relevant public interest of the Fed-
eral Government, according to the provisions of a supplementary
law."' 9 3 Accordingly, section 6 opens the door to legislation permitting
the commercialization and access to the biodiversity of the land occu-
pied by indigenous people.
The Constitution was adopted in 1988 and set federal standards
for any laws that Congress enacts.194 Under its provisions, the govern-
ment has the responsibility to follow these standards for scientific
development, conservation of biodiversity, and protection of indigenous
people.' 95 In 1994, the Brazilian government ratified the CBD and
since then, Brazil has enacted various laws to implement the CBD into
the domestic legal framework.196 The Constitution and other laws cre-
ated instruments and governmental institutions to regulate the
country's vast biodiversity.
188. C.F. art. 225.
189. Id.
190. Id. at § 1 (II).
191. C.F. art. 231.
192. Id. at § 1.
193. Id. at § 6.
194. Scott, supra note 183, at 985.
195. Id.
196. Id. at 987.
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2. Provisional Measure and other Decrees
The Provisional Measure (Medida Provis6ria "MP") is an instru-
ment the President uses to address priority matters.19 7 It is defined as
a law enacted by the President when urgent and relevant matters
needs to be regulated without congressional authorization.1 9 8 Article
62 of The Constitution provides that the MP has limited validity until
Congress approves it to become law.199 However, in 2001, Constitu-
tional Amendment No. 32 changed this requirement by allowing the
MP to be binding even in the absence of Congress' action.200 When
Congress acts, the MP is transformed into a Legislative Decree. 201
MP 2186 is a primary example of the Brazilian government's
attempt to regulate access to genetic resources and traditional knowl-
edge. 202 The MP implements CBD's provision establishing a country's
sovereign right to exploit its own resources, by defining genetic re-
sources as "information of genetic origin from all or part of microbial,
fungal, plant or animal species found in or coming from Brazilian terri-
tory, including the continental shelf and exclusive economic zone."203
MP 2186 covers several issues and it is being criticized for being
too vague and too broad regarding biodiversity conservation and tradi-
tional knowledge protection. 204 Article 2 establishes that "the access to
the country's existent genetic patrimony could only be done with fed-
eral authorization."20 5 Article 2 also acknowledges benefit-sharing. 206
The problem is that MP 2186 is not clear on how the access and bene-
fit-sharing will be accomplished. 2 0 7
197. John Tustin, Traditional Knowledge and Intellectual Property in Brazilian
Biodiversity Law, 14 TEX. INTELL. PROP. L.J. 131, 145 (2006) (internal citations omitted)
[Tustin].
198. Ana Clafidia Manso S.O. Rodrigues, A Medida Provis6ria ndo Convertida em Lei e
a Edigdo de Decreto Legislativo [The Provisional Measure not Converted into Law and the
Creation of Legislative Decree], Revista de Direito Pfiblico [Public Law Magazine] 142
(2003) (Br.) available at http://www.direitopublico.idp.edu.br/index.php/direitopublico/
article/viewFile/506/51 1.
199. Id.
200. Id.
201. Id. at 143.
202. Tustin, supra note 197, at 145.
203. Id. See MP, supra note 5, at art. 1 (I).
204. Id. at 146-147.
205. MP, supra note 5, at art. 2.
206. Id.
207. Tustin, supra note 197, at 147.
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MP 2186 provides that commercial use of genetic resources or
traditional knowledge requires access contracts. 208 The contracts must
contain a clause that involves "fair and equitable sharing" and must
establish that access will only be allowed if there is a benefit in re-
turn.20 9 However, the MP is vague because it does not define "fair and
equitable sharing."2 10 The MP does list what constitutes benefits,
which are: sharing of profits; payment of royalties; technology transfer;
licensing of products and processes without cost; and capacity building.
Without the definition of "fair and equitable sharing," it is not clear
how "fair" the benefits listed may be.2 1 1
Accordingly, profits and royalties are some of the benefits recog-
nized by the MP 2186. Article 33 provides that the payments of profits
and royalties owed to the Federal Government shall be distributed to
some federal agencies listed within the provision. 212 It also mandates
that such monetary resources shall be used for the conservation of bio-
logical diversity and for the capacitating of human resources.213
However, since the parties seem to have freedom to contract and there
is no requirement that all contracts must be made with governmental
agencies, the profit and royalties do not need to be used towards con-
servation when contracts are made between private parties. Moreover,
there is no existing agency that oversees the terms of individual con-
tracts to ensure that the terms are fair and equitable. 214 Mechanisms
to distribute benefits are also absent. 2 15
MP 2186 Article 7 defines "associated traditional knowledge" as
the "individual or collective information or practice of the indigenous
community or local community, with real or potential value, associated
to genetic heritage."216 "Local community" is culturally distinct indige-
nous and quilombolas populations that maintain their traditional
social and economic institutions. 2 17 The MP 2186 does not define "indi-
vidual" or "collective" practices.218 MP 2186 is also silent on who is
208. NASCIMENTO, supra note 15, at 90.
209. Id.
210. Id.
211. MP, supra note 5, at art. 25.
212. Id. at art. 33.
213. Id.
214. Tustin, supra note 197, at 148-9.
215. Id.
216. Id. See MP, supra note 5, at art. 7 (II).
217. Id. at 146.
218. Id.
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responsible for indigenous and local communities to decide how to use
their traditional knowledge.219
The MP provisions on access to genetic resources mandate that
resources existing in "in situ" conditionS220 be provided only for Brazil-
ian entities.221 Therefore, a foreign company is required to partner
with a Brazilian organization, which would be the controlling part-
ner.2 2 2 The MP also provides that access to a genetic resource needs
prior informed consent ("PIC").223
Although the MP does not define PIC, it lists the parties that
are authorized to give consent.224 The list includes the indigenous com-
munity involved, environmental protection agency, private property
owners, the National Defense Council, and the maritime authority.225
The listing of parties helps; however, the lack of description of what
PIC is causes confusion because it is not clear what members of the
parties listed are competent to give effective informed consent, espe-
cially when it applies to traditional communities. 226
After the President created the MP 2186, Congress enacted
other laws regulating the commercial use of genetic resources and as-
sociated traditional knowledge.227 This type of legislation is called a
Legislative Decree.228 Decree 3945/2001 created the federal agency
called Genetic Resources Management Council ("CGEN") as required
in Article 10 of MP 2186.229 CGEN has the authority to establish regu-
lations for the genetic patrimony management, to create and maintain
databases on traditional knowledge relevant to the conservation of bi-
odiversity and to establish guidelines for the approval process for
genetic access contracts. 230 CGEN only has authority to oversee con-
tracts where the federal government is a party; it does not have
219. Id.
220. MP, supra note 5, at art. 16. See CDB, supra note 3, at art. 2( "In-situ conditions"
means conditions where genetic resources exist within ecosystems and natural habitats,
and, in the case of domesticated or cultivated species, in the surroundings where they have
developed their distinctive properties.)
221. Id.
222. Tustin, supra note 197, at 146-7.
223. Id.
224. Id.
225. Id.
226. Id.
227. Id. at 148-149.
228. Id. See Decree 3945/2001 available at http://www.planalto.gov.br/ccivil_03/decreto/
2001/D3945.htm. (last visited)
229. Id.
230. Id.
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authority to manage the "fair and equitable sharing" of private access
contracts.231
The MP 2186 provision on IPRs is very similar to the CBD.232
Protection of traditional knowledge associated with biodiversity is
awarded as long as it does not affect, damage, or limit intellectual
property rights. 233 Article 28 requires that access contracts carry IPRs
clauses. 234 In addition, Decree 5.450/2005 created administrative fines
and penalties for the misuse of genetic resources or traditional knowl-
edge. 2 35 Some scholars criticize such provisions because they
contribute to biopiracy. Once intellectual property is protected, patents
obtained without contracts will preclude any kind of benefit-sharing. 236
Moreover, administrative penalties are not enough to protect biodiver-
sity.237 The only way to avoid biopiracy is the criminalization of this
type of activity or effective bioprospecting agreements. 238
The most prominent Brazilian newspaper, 0 Globo, printed an
article acknowledging that the Brazilian government has its "hands
tied" with respect to the threat of biopiracy. 239 The Secretary of Bio-
diversity and Forests Ministry of Environment and CGEN's Chairman,
Braulio Dias, admitted that the government's hands are tied due to the
escalation of illegal exploitation of genetic biodiversity, a practice
known as biopiracy.240 According to Dias, the absence of a regulatory
framework to curb this incalculable damage to the public and the envi-
ronment make it impossible to stop biopiracy.241 Currently, the
government is limited to the Provisional Measure 2186, published ten
years ago. For Braulio Dias, the MP is "full of imperfections," for exam-
ple, it does not define how the royalties may be paid by the
industries.242 "This MP should no longer be in effect. Urge to be re-
placed by a law. . we work with incoming orders to CGEN case-by-
231. Id. See Resolution 27, available at http://www.mma.gov.br/estruturas/sbf dpg/
arquivos/res27.pdf.
232. Id. at 148.
233. Id.
234. MP, supra note 5, at art. 28.
235. Wandscheer, supra note 6, at 11.
236. Id.
237. Id. at 12.
238. NASCIMENTO, supra note 15, at 91.
239. See Emanuel Alencar, 0 Governo Admite Estar de "Mdos Atadas" Diante da
Ameaga de Biopirataria [The Government Admits its "Hand are Tied" Before the Threat of
Biopiracy], 0 Globo, Apr. 21, 2011, http://oglobo.globo.com/economia/mat/2011/04/21/
governo-admite-estar-de-maos-atadas-diante-da-ameaca-da-biopirataria-924295307.asp.
240. Id.
241. Id.
242. Id.
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case. The amount being paid by companies to the federal government is
very low." 2 4 3 According to 0 Globo, more than 100 research institutions
and companies in the areas pharmaceutical, food, agricultural, cos-
metic, fragrance and new materials have already been notified to
submit information and documents proving the legality of their activi-
ties on biodiversity elements in Brazil.244 Braulio Dias said "we must
provide a return to society. The MP is very bureaucratic and does not
create incentives for research. We have to punish, but also
stimulate."245
3. Bioprospecting Contract
Despite the existence of an extensive body of normative regula-
tions regarding the access to biodiversity, there are many practical
impediments to the appropriate enforcement of such regulations. 246
The protection of genetic resources is therefore ineffective in Brazil.247
Before the enactment of the MP 2186, Brazil's Association for
the Sustainable Use of the Biodiversity of Amazonia (BIOAMAZONIA)
entered into a three-year bioprospecting contract with the Swiss phar-
maceutical company Novartis Pharmaceuticals ("Novartis").248
Novartis agreed to pay BIOAMAZONIA $4 million from worldwide
sales.249 Novartis contracted for the right to create new products from
the extracts of biological samples, and that they would have the exclu-
sive right to use the extracts for a period of ten years after the
product's invention. 25 0 BIOAMAZONIA in return would receive 1.6
million Brazilian reais251 for each product clinically tested, R$ 750,000
for each patent registered, R$ 500,000 on the first day a product is
placed on the market, and one percent of all royalties over a period of
ten years.252
243. Id.
244. Id.
245. Id.
246. Id.
247. Id. at 90.
248. Ragavan, supra note 11, at 518.
249. Id.
250. Scott, supra note 183, at 979-980.
251. Id. See "The real (pl. reais) is the present-day currency of Brazil. Its sign is R$ and
its ISO code is BRL. It is subdivided into 100 centavos ("hundredths"). In Brazil, the decimal
separator is a comma, and a period may be used as thousands separator, as in "R$
123.456,78"." http://en.wikipedia.org/wikilBrazilian-real. See also Jeff Fick, Brazil Currency
Market Stronger on U.S. Debt Deal (August 1, 2011), Wall Street Journal, $1 = R$1,5465,
http://online.wsj.com/article/BT-CO-20110801-707342.html.
252. Id.
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Opponents of the contract claimed that it would cause serious
harm to the environment.253 They also claimed that it was a usurpa-
tion of traditional knowledge because did not provide for investment in
conservation or compensation for the traditional communities.254
The BIOAMAZONIA-Novartis agreement violates many Arti-
cles of the Constitution.255 It violates Article 218 because the research
is not focusing on Brazilian problems as the Constitution requires. 256
The problem Brazil faces is the widespread depletion and exploitation
of Amazonia's biodiversity and therefore any scientific research has to
take that into consideration. 257 Critics say that the BIOAMAZONIA-
Novartis agreement allows for a large-scale form of biopiracy in the
collection and exportation of some 30,000 biological samples, author-
ized by the government through executive decree.258
Moreover, the agreement does not add to the development of
Brazilian science and technology, it impedes the growth of Brazilian
research by removing the materials that could have been the subject of
scientific investigations and, it prevents the training of Brazilian scien-
tists in new techniques contributing to loss of job opportunities for the
economic growth of the country.259 It also violates Article 225 because
the agreement fails to safeguard the environment by allowing Novartis
to remove 30,000 biological samples from the Amazon. 260
After strong public opposition calling the BIOAMAZONIA-
Novartis agreement a legalized form of biopiracy, the Brazilian govern-
ment cancelled the contract.261 Shortly thereafter, the President
signed the MP 2186.262 The vague language of the MP and its deriva-
tive Decrees scared the international community, which impeded the
realization of other bioprospecting contracts. 263 The result is an ongo-
ing legacy of the illegal exploitation of the Brazilian natural
resources. 264
253. Id.
254. Id.
255. Id.
256. Id.
257. Id.
258. Id.
259. Id. at 990-991.
260. Id.
261. Id.
262. Id.
263. Id.
264. Charles Roland Clement, Um Pote de Ouro no Fim do Arco-Iris? 0 Valor da
Biodiversidade e do Conhecimento Tradicional Associado, e as Mazelas da Lei de Acesso:
Uma Visdo e Proposta a partir da Amaz6nia [A Gold Pot in the End of a Raibow? The Value
of Biodiversity and Traditional Knowledge Associated, and the Shortcoming of the Access
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The problematic legislation is an obstacle to the creation of con-
tracts that could actually benefit Brazil and stop biopiracy.265 If well
established, bioprospecting contracts could require parties to set funds
towards creating jobs for Brazilian scientists, compensation for tradi-
tional communities and, most importantly, set aside funds designated
to biodiversity conservation.
B. Costa Rica Anti-Biopiracy Success Program: INBios
Costa Rica is a small Central American country, with a land
area of only 51,100 square kilometers (0.03% of the planet's surface)
and 589,000 square kilometers of territorial waters. 266 Despite its
small size, Costa Rica is one of the twenty countries with the greatest
biodiversity in the world. 2 6 7 There are more than 500,000 species found
in the country, which represent nearly 4% of the total species esti-
mated worldwide. 268
To protect such rich biodiversity, Costa Rica had created a com-
prehensive legal framework for the conservation and sustainable use of
biodiversity.269 Costa Rica is also a party to the CBD and had imple-
mented its provisions into domestic law with special attention to the
benefit-sharing provision. 270
In 1989, The National Biodiversity Institute ("INBio") of Costa
Rica was created to support the country's conservation efforts and to
promote sustainable development. 271 INBio is a private, non-govern-
mental, non-profit, public interest organization that works with
different governmental institutions, universities, the private sector,
and other domestic and international public and private organiza-
tions.272 Its philosophy is to conserve biodiversity through study,
research and improvement of the people's quality of life. 273
Law: A View and Proposal from the Amazon), 3 Amaz6nia: Ci. & Desenvol. 180 (2007) (Br.)
available at http-//www.basa.com.br/bancoamazonia2/Revistaedicao05/C&DVolVPote_
ouro_fim arco-ir.pdf.
265. Id.
266. INBio, Biodiversity in Costa Rica, http://www.inbio.ac.cr/en/biodbio-biodiver.htm.
(last visited).
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INBio is considered to have broken new ground for bioprospect-
ing contracts. 27 4 It established research agreements for the study of
chemical substances and genes present in plants, insects, and marine
organisms and microorganisms, which may be utilized by the pharma-
ceutical, medical, biotechnology, cosmetics, food and agricultural
industries. 275
The most recognized and publicized bioprospecting agreement
is the Merck-INBio agreement. 276 Merck is a U.S.-based pharmaceuti-
cal company.277 The parties entered into a contract in 1991 and
subsequently renewed the contract many times. 278 The agreement pro-
vides that INBio would allow Merck's access to "chemical extracts from
wild plants, insects, and micro-organisms" in exchange for an up-front
fee of $1 million.2 79 The agreement also provides that Merck is re-
quired to build a facility and fund the education and training of local
scientists.2 80 Merck had spent $135,000 on equipment, the setting up
of the facilities, and the training of INBio scientists in the extraction
process. 281 Another advantage of the agreement is that INBio would
receive 3% of worldwide sales from royalties on products developed in
accordance with the agreement. 282
The Merck-INBio agreement is a good example of a bioprospect
contract, which the funds are used towards biodiversity conserva-
tion. 283 The agreement stipulates that INBio contribute 10% of the up-
front fee and 50% of any future royalties to the National Parks Fund to
be invested in conservation. 2 84
Although the Merck-INBio agreement is a good example of how
bioprospecting contracts can help preserve biodiversity and promote
sustainable development by empowering the local workforce and by
creating well-established mechanisms for better distribution of funds,
the Merck-INBio enterprise failed to take into consideration the role of
traditional knowledge in obtaining the genetic material.285 Biopros-
pecting contracts should have clauses to recognize the traditional
274. Id.
275. Id.
276. HUNTER, supra note 69, at 1038.
277. Id.
278. Id.
279. Scott, supra note 183, at 996-8.
280. Id.
281. Id.
282. Ragavan, supra note 11, at 517.
283. Id.
284. Id.
285. Id.
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communities' rights to biodiversity and their knowledge by providing a
reasonable amount of compensation directly proportional to the mil-
lions of dollars made in profit for the use of genetic resources. 286
Despite the shortcomings regarding compensation for tradi-
tional knowledge, the Merck-INBios agreement is a success because it
generated incentives to benefit Costa Rica's environment, such as the
creation of the Wildlife Conservation Law.2 87 INBio also entered into
agreements with the U.S. biotechnology company Recombinant Bio-
Catalysis, Inc., and also the U.S. computer company Intergraph
Corporation. Both agreements led to improvement for the sustainable
development of Costa Rica. 28 8
V. PROPOSALS FOR BRAZIL TO STOP BioPiRAcY AND PRESERVE THE
AmAZON's BIODIVERSITY
Brazil should learn from its failed attempts to negotiate the use
of its biodiversity. Drawing from India's experience in fighting U.S.
patent laws, and from Costa Rica's successful bioprospecting contracts,
Brazil needs to refine its goals toward biodiversity conservation, sus-
tainable development, and protection of the traditional knowledge
associated to the use of genetic resources. Brazil should continue its
efforts to negotiate amendments to TRIPS regarding patents of plant
varieties to include a disclosure mechanism. 289
Additionally, Brazil should pursue better-drafted legislation
that would set standards for the benefit-sharing provision of the CBD
and the Nagoya Protocol, where a fair and equitable distribution of re-
sources would promote Brazil's continued growth without
environmental degradation. The new legislation should adopt the con-
stitutional standards and create a new institution, or empower an
existing one, with the sole responsibility of managing the bioprospect-
ing contracts to ensure that they are in line with CBD's goals. These
steps would ensure that the Amazon biodiversity would be available to
future generations worldwide.
286. SHIVA, supra note 19, at 72-79.
287. Ragavan, supra note 11, at 518. The Wildlife Conservation Law requires agencies
to negotiate bioprospecting contracts for the benefit of the environment. Id.
288. Scott, supra note 183, at 997.
289. Brazil has sent several proposals to the WTO and to the World Intellectual
Property Organization (herein WIPO). See http://www.wipo.int/portallindex.html.en (search
for "Brazil proposals").
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A. Improve Bioprospecting Contracts
Bioprospecting is not new in human history.290 For millions of
years, humanity has used natural resources to improve the way of
life.29 1 Bioprospecting has been defined as the exploitation and devel-
opment of genetic material found in biodiversity for commercial
purposes.292
Technological advances throughout the years had made biopros-
pecting a very profitable activity for industries. 293 Behind its
legitimate appearance, bioprospecting has been viewed as suspicious
due to the claims of biopiracy against industries' activities in countries
rich in biodiversity. 294
CBD created the awareness for developing countries of their
sovereignty rights over natural resources and the possibility of receiv-
ing profits generated by the commercialization of its genetic material
by foreign industries. 295 The best way to ensure an equitable and fair
participation of the provider country is through bioprospecting con-
tracts. 296 Bioprospecting is as an incentive to developing countries to
preserve biodiversity and improve traditional communities' way of
life.297
Bioprospecting agreements that ignore conservation and tradi-
tional knowledge associated with the use of genetic resources violate
CBD's end goals and facilitate biopiracy practices.298 An example is the
BIOAMVAZIONA-Novartis agreement.
There are many differences between Brazil's BIOAMAZONIA-
Novartis contract and Costa Rica's successful INBio-Merck contract.299
First, no biological samples are removed from Costa Rica because IN-
Bio provides chemical extracts and not actual specimens to Merck,
while Novartis was allowed to collect and export the specimens.300 Sec-
ond, Costa Rica invests in hiring locals trained by Merck scientists to
290. Laird, supra note 10, at 22.
291. Id.
292. Id.
293. Id.
294. MICHELANGELO GIorro SANTORO TRIGUEIRO, SOCIOLOGIA DA TECNOLOGIA:
BIOPROSPEQAO E LEGITIMAQAO [SOCIOLOGY OF TECHNOLOGY: BIOPROSPECTING AND
LEGITIMATION] 115 (Centauro ed., 2009) (Br.).
295. Id.
296. Id. at 116.
297. Id.
298. Ragavan, supra note 11, at 518
299. Id.
300. Scott, supra note 183, at 997.
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collect the specimens and perform all extractions in Costa Rican labo-
ratories, which in turn creates new jobs for the Costa Rican
economy.301 Since Novartis would do all the work to extract the genetic
material, no creation of new jobs in Brazil was necessary because the
contract provided that the research would be performed in Switzerland
without the need for Brazilian scientists. 302 Third, although
BIOAMAZONIA intended to use some proceeds towards sustainable
development, it has not done so in a concrete manner.303 Finally, the
BIOAMAZONIA agreement did not establish mechanisms to set aside
funds for biodiversity conservation. 30 4 For all of these reasons, the
BIOAMAZONIA-Novartis bioprospecting contract was considered bi-
opiracy rather than bioprospecting evidenced in the INBio-Merck
agreement.
Another good example of a successful bioprospecting contract is
the CSIRIPhytopharm agreement. Phytopharm, a British company, en-
tered into an agreement with the CSIR, a South-African research
organization, to commercialize Hoodia, a plant responsible for sup-
pressing appetite.30 5 For years, hoodia had been used by the San, an
African traditional community.306 Due to NGOs' pressure and media
interest, the CSIR entered into an agreement with the San to imple-
ment the benefit-sharing requirements of the CBD. 0 7
Brazil should learn from its past failures and consider Costa
Rica's and South Africa's models for future bioprospecting contracts. In
adopting such models, Brazil should consider improvements such as
addressing traditional communities' participation and providing them
with adequate monetary compensation in exchange for their knowl-
edge. Given that the use of genetic resources could generate multi-
million dollar profits for the parties to the contract, some of the money
should be directed to conservation of the Amazon.
301. Id.
302. Id.
303. Id.
304. Id.
305. Laird, supra note 10, at 27-28.
306. Id. The San are a group of marginalized people with a long history of oppression,
persecution and relocation. See R.K. Hitchcock and M. Biesele, San, Khwe, Basarwa, or
Bushmen? Terminology, Identity and Empowerment in Southern Africa (2001), available at
http://www.kalaharipeoples.org/documents/San-term. (last visited).
307. Id. The San did not know that their knowledge for the use of Hoodia could be
commercialized.
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B. Strengthen Existing Legislation
Brazil is a developing country and therefore a major stake-
holder when it comes to bioprospecting contracts that could potentially
generate million of dollars to the economy.308 In order to raise credibil-
ity with the international community, Brazil has to improve its current
legislation.309
Brazil is party to the CBD and to the Nagoya Protocol, and has
implemented the access to genetic resources and traditional knowledge
through the MP 2186.310 In compliance with the MP, Brazil created the
CGEN, which is the agency responsible for the evaluation of research
projects related to genetic patrimony and traditional knowledge for sci-
entific purposes, bioprospecting and technological development.311
However, there are other institutions accredited by CGEN that are
also responsible for allowing research and access to genetic resources,
such as IBAMA and the National Council for Scientific and Technologi-
cal Development (CNPq).312 These institutions are able to issue
permits for access to genetic resources. 313 However, a problem arises
because this decentralized system makes enforcement very difficult.314
The fragmentation of agencies makes the process more bureaucratic
where many steps are necessary to acquire a permit.3 15
According to existing laws, a company interested in research
and use of Brazilian biodiversity should provide the necessary docu-
mentation before beginning research and also request authorization
from the competent institutions.3 1 6 However, when multiple agencies
are authorized to oversee and enforce biodiversity research, it creates
confusion.317
In 2007, the Brazilian government created the Chico Mendes
Institute for Biodiversity Conservation ("ICMBio").318 ICMBio is under
308. Scott, supra note 183, at 998.
309. Id.
310. Fernanda Alvares Silva and Laila Salmen Espindola, Access Legislation on Genetic
Resources Patrimony and Traditional Knowledge, 21 Rev.bras. Farmacogn. 1 (2011)
available at http://www.scielo.br/scielo.php?script=sci-arttext&pid=S102695X201100010
0001&lng=en&nrm=iso&tlng=en.
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315. Tustin, supra note 197, at 149.
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318. ICMBio, http://www.brasil.gov.br/sobre/geography/bodies/chico-mendes-institute-
for-biodiversity-conservation-201cicmbio20ld-1/brmodell?setlanguage=en.
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the Ministry of Environment and has the responsibility to create poli-
cies for the sustainable use of renewable natural resources and support
of communities located in federal conservation areas.3 19 Moreover, it
helps to recover degraded sections in protected areas, and may penal-
ize those who do not meet the required measures for the preservation
of nature or the correction of environmental degradation. 320
Although Brazil created a reasonable legal framework in imple-
menting the CBD's and the Nagoya Protocol's goals, the laws are vague
and therefore need improvement. A good example would be a provision
that centralizes the national biodiversity policies into the competence
of one agency or institution. The law should have more specific and
clear language to make the agency's work more transparent for the
Brazilian public and for the international community.
The ICMBio, for example, could be assigned by law as a substi-
tute for the BIOAMAZONIA, since the institution is already committed
to ensure conservation and sustainable development. The ICMBio
could be responsible for bioprospecting contracts following the Costa
Rica's INBios model.
CONCLUSION
The Brazilian Amazon is the largest unspoiled tropical
rainforest in the world. The conservation of its biodiversity is a priority
for the Brazilian government and for the population in general, but
especially for the traditional communities that inhabit the forest and
depend on its natural resources to survive. The best policy approach to
conserve Amazon biodiversity is to embrace globalization and promote
sustainable development associated with the production and commer-
cialization of products from the Amazon.
The Brazilian Amazon is also a matter of extreme significance
for the international community since they view the Amazon as indis-
pensable for a well-balanced planet and as the "world's lungs" because
is a major carbon sink on the fight of climate change impacts. 321
Brazil can increase the economic benefits of the exploitation of
the Amazon genetic resources without contributing to environmental
degradation. The benefits need to be adequately shared to prevent bi-
opiracy and intellectual property rights from endangering the Amazon
biodiversity.
319. Id.
320. Id.
321. HUNTER, supra note 69, at 637. See Scott Wallace, Last of the Amazon, National
Geographic, Jan. 2007, at 40-49.
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In order to achieve sustainable development in the Amazon and
to comply with CBD's benefit-sharing objectives, Brazil needs a new
uniform legal framework with strong enforcement mechanisms to reg-
ulate bioprospecting contracts and protect the use of genetic resources
and traditional knowledge associated for optimal environmental
conservation.
$88
